Naltrexone treatment produces dose-related effects on food and water intake but daily alcohol consumption is not affected

References

• Gianoulakis C. Characterization of the effects of acute ethanol administration on the release of beta-endorphin peptides by the rat hypothalamus. Eur J Pharmacol 1990; 180: 21–29.
   PubMed Web of Science ®Google Scholar
• Gianoulakis C, Krishnan B, Thavundayil J. Enhanced sensitivity of pituitary ß-endorphine to ethanol in subjects at high risk of alcoholism. Arch Gen Psychiatry 1996; 53: 250–257.
   PubMed Web of Science ®Google Scholar
• O’Malley SS. Opioid antagonist in the treatment of alcohol dependence: clinical efficacy and prevention of relapse. Alcohol Alcohol 1996; 1:77–81.
   Google Scholar
• Volpicelli JR, Clay KL, Watson NT, O’Brien CP. Naltrexone in the treatment of alcoholism: predicting response to naltrexone. J Clin Psychiatry 1995; 56: 39–44.
   PubMed Web of Science ®Google Scholar
• Guardia J, Caso C, Arias F, et al. A double-blind, placebocontrolled study of naltrexone in the treatment of alcohol- dependence disorder: results from a multicenter clinical trial. Alcohol Clin Exp Res 2002; 26: 1381–1387.
   PubMed Web of Science ®Google Scholar
• McCaul ME, Wand GS, Stauffer R, Lee SM, Rohde CA. Naltrexone dampens ethanol-induced cardiovascular and hypothalamic-pituitary-adrenal axis activation. Neuropsychopharmacology 2001; 25: 537–547.
   PubMed Web of Science ®Google Scholar
• Heinälä P, Alho H, Kiianmaa K, Lonnqvist J, Kuoppasalmi K, Sinclair JD. Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial. J Clin Psychopharmacol 2001; 21:287–292.
   PubMed Web of Science ®Google Scholar
• Sinclair JD. Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism. Alcohol Alcohol 2001; 36:2–10.
   PubMed Web of Science ®Google Scholar
• Hyytia P, Ingman K, Soini SL, Laitinen JT, Korpi ER. Effects of continuous opioid receptor blockade on alcohol intake and up- regulation of opioid receptor subtype signaling in a genetic model of high alcohol drinking. Naunyn-Schmiedeberg’s Arch Pharmacol 1999; 360: 391–401.
   Google Scholar
• Gardell LR, Hubbell CHL, Reid LD. Naltrexone persistently reduces rats’ intake of a palatable alcoholic beverage. Alcohol Clin Exp Res 1996; 20: 584–588.
   PubMed Web of Science ®Google Scholar
• Gardell LR, Reid LD, Boedeker KL, Liakos TM, Hubell CL. Isradipine and naltrexone in combination with isradipine interact with a period of abstinence to reduce rats’ intakes of an alcoholic beverage. Alcohol Clin Exp Res 1997; 21: 1592–1598.
   PubMed Web of Science ®Google Scholar
• Gardell LR, Whalen CA, Chattophadyay S, Cavallaro CA, Hubbell CL, Reid LC. Combination of naltrexone and fluoxetine on rats propensity to take alcoholic beverage. Alcohol Clin Exp Res 1997; 21: 1435–1439.
   PubMed Web of Science ®Google Scholar
• Williams KL, Woods JH. Naltrexone reduces ethanol and/or water-reinforced responding in rhesus monkeys: effect depends upon ethanol concentration. Alcohol Clin Exp Res 1999; 23: 1462–1467.
   PubMed Web of Science ®Google Scholar
• Hill KG, Kiefer W. Naltrexone treatment increases the aversiveness of alcohol for outbred rats. Alcohol Clin Exp Res 1997; 21: 637–642.
   PubMed Web of Science ®Google Scholar
• Stromberg MF, Volpicelli JR, O’Brien CP. Effects of naltrexone administered repeatedly across 30 and 60 days on ethanol consumption using a limited access procedure in the rat. Alcohol Clin Exp Res 1998; 22: 2186–2191.
   PubMed Web of Science ®Google Scholar
• Stromberg MF, Sengpiel T, Mackler SA, Volpicelli JR, O’Brien CP, Vogel WH. Effect of naltrexone on oral consumption of concurrently available ethanol and cocaine in the rat. Alcohol 2002; 28: 169–179.
   PubMed Web of Science ®Google Scholar
• Parkes H, Sinclair JD. Reduction of alcohol drinking and upregulation of opioid receptors by oral naltrexone in AA rats. Alcohol 2000; 21:215–221.
   PubMed Web of Science ®Google Scholar
• Reid LD, Gardell LR, Chattopadhyay S, Hubbell ChL. Periodic naltrexone and propensity to take alcoholic beverage. Alcohol Clin Exp Res 1996; 20: 1329–1334.
   PubMed Web of Science ®Google Scholar
• Goodwin FL, Campisi M, Babinska I, Amit Z. Effects of naltrexone on the intake of ethanol and flavored solutions in rats. Alcohol 2001; 25:9–19.
   PubMed Web of Science ®Google Scholar
• Coonfield DL, Kiefer SW, Ferraro 3rd FM, Sinclair JD. Ethanol palatability and consumption by high ethanol-drinking rats: manipulation of the opioid system with naltrexone. Behav Neurosci 2004; 118: 1089–1096.
   PubMed Web of Science ®Google Scholar
• Phillips TJ, Wenger ChD, Dorow JD. Naltrexone effects on ethanol drinking acquisition and on established ethanol consumption in C57BL/6J mice. Alcohol Clin Exp Res 1997; 21: 691–702.
   PubMed Web of Science ®Google Scholar
• Lang IM, Strahlendorf JC, Strahlendorf HK, Barnes CD. Effects of chronic administration of naltrexone on appetitive behaviors of rats. Prog Clin Biol Res 1981; 68: 197–207.
   PubMedGoogle Scholar
• Marks-Kaufman R, Balmagiya T, Gross E. Modification in food intake and energy metabolism in rats as a function of chronic naltrexone infusions. Pharmacol Biochem Behav 1984; 20, 911–916.
   PubMed Web of Science ®Google Scholar
• Jones JE, Corp ES. Effect of naltrexone on food intake and body weight in Syrian hamsters depends on metabolic status. Physiol Behav 2003; 78: 67–72.
   PubMed Web of Science ®Google Scholar
• Kotz CM, Glass MJ, Levine AS, Billington CJ. Regional effect of naltrexone in the nucleus of the solitary tract in blockade of NPY- induced feeding. Am J Physiol 2000; 278: R499 -R503.
   Web of Science ®Google Scholar
• Davidson D, Amit Z. Effect of ethanol drinking and naltrexone on subsequent drinking in rats. Alcohol 1997; 14: 581–584.
   PubMed Web of Science ®Google Scholar
• Bertino M, Beauchamp GK, Engelman K. Naltrexone, an opioid blocker, alters taste perception and nutrient intake in humans. Am J Physiol 1991; 261: R59 -R63.
   PubMed Web of Science ®Google Scholar
• Spiegel TA, Stunkard AJ, Shrager EE, O’Brien CP, Morrison MF, Stellar E. Effect of naltrexone on food intake, hunger and satiety in obese men. Physiol Behav 1987; 40: 135–141.
   PubMed Web of Science ®Google Scholar
• Yeomans MR, Gray RW. Opioid peptides and the control of human ingestive behaviour. Neurosci Biobehav Rev 2002; 26: 713–728.
   PubMed Web of Science ®Google Scholar
• Yeomans, MR, Gray, RW. Effects of naltrexone on food intake and changes in subjective appetite during eating: evidence for opioid involvement in the appetizer effect. Physiol Behav 1997; 62: 15–21.
   PubMed Web of Science ®Google Scholar
• Lang IM, Strahlendorf JC, Strahlendorf HK, Lutherer LO, Barnes CD. The effects of chronic administration of naltrexone on appetitive and water exchange in rats. Pharmacol Biochem Behav 1982; 16:909–913.
   PubMed Web of Science ®Google Scholar
• Tannenbaum MG, Pivorun EB. Effect of naltrexone on food intake and hoarding in white-footed mice (Peromyscus). Pharmacol Biochem Behav 1984; 20: 35–37.
   PubMed Web of Science ®Google Scholar
• Kirkham TC, Blundell JE. Effects of naloxone and naltrexone on meal patterns of freely-feeding rats. Pharmacol Biochem Behav 1987; 26:515–520.
   PubMed Web of Science ®Google Scholar
• Hobbs DJ, Koch JE, Bodnar RJ. Naltrexone, dopamine receptor agonists and antagonists and food intake in rats: 1. Food deprivation. Pharmacol Biochem Behav 1994; 49: 197–204.
   PubMed Web of Science ®Google Scholar
• MacDonald AF, Billington CJ, Levine AS. Effects of the opioid antagonist naltrexone on feeding induced DAMGO in the ventral tegmental area and in the nucleus accumbens shell region in the rat. Am J Physiol 2003; 285: R999 -R1004.
   PubMed Web of Science ®Google Scholar
• Littleton J, Zieglgänsberger W. Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence. Am J Addict 2003; 12 (Suppl 1): S3–S11.
   PubMed Web of Science ®Google Scholar
• Kornet M, Goosen C, Van Ree JM. Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys. Psychopharmacology 1991; 104: 367–376.
   PubMed Web of Science ®Google Scholar
• Gonzalez JP, Brogden RN. Naltrexone: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs 1988; 35: 192–213.
   PubMed Web of Science ®Google Scholar
• Sinclair JD. Drugs to decrease alcohol drinking. Ann Med 1990; 22: 357–362.
   PubMed Web of Science ®Google Scholar
• Juarez J, Barrios De Tomasi E. Alcohol consumption is enhanced alter naltrexone treatment. Alcohol Clin Exp Res 2007; 31: 260–264.
   PubMed Web of Science ®Google Scholar
• Biggs TA, Myers RD. Naltrexone and amperozide modify chocolate and saccharin drinking in high alcohol-preferring P rats. Pharmacol Biochem Behav 1998; 60: 407–413.
   PubMed Web of Science ®Google Scholar
• Hölter SM, Spanagel R. Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats. Psychopharmacology 1999; 145: 360–369.
   PubMed Web of Science ®Google Scholar
• Hollister LE, Johnson K, Boukhabza D, Gillespie HK. Aversive effects of naltrexone in subjects not dependent on opiates. Drug Alcohol Depend 1981; 8: 37–41.
   PubMed Web of Science ®Google Scholar
• Kanarek RB, Mathes WF, Heisler LK, Lima RP, Monfared LS. Prior exposure to palatable solutions enhances the effects of naltrexone on food intake in rats. Pharmacol Biochem Behav 1997; 57: 377–381.
   PubMed Web of Science ®Google Scholar
• Apfelbaum M, Mandenoff A. Naltrexone suppresses hyperphagia induced in the rat by a highly palatable diet. Pharmacol Biochem Behav 1981; 15:89–91.
   PubMed Web of Science ®Google Scholar
• Cooper SJ, Turkish S. Effects of naltrexone on food preference and concurrent behavioral responses in food-deprived rats. Pharmacol Biochem Behav 1989; 33: 17–20.
   PubMed Web of Science ®Google Scholar
• Chen RZ, Huang RR, Shen CP, MacNeil DJ, Fong TM. Chronic administration of nalmefene leads to increased food intake and body weight gain in mice. Eur J Pharmacol 2004; 495: 63–66.
   PubMed Web of Science ®Google Scholar
• Rukstalis MR, Stromberg MF, O’Brien CP, Volpicelli JR. 6-beta- naltrexole reduces alcohol consumption in rats. Alcohol Clin Exp Res 2000; 24: 1593–1596.
   PubMed Web of Science ®Google Scholar
• Stomberg MF, Rukstalis MR, Mackler SA, Volpicelli JR, O’Brien CP. A comparison of the effects of 6-beta naltrexole and naltrexone on the consumption of ethanol or sucrose using a limited-access procedure in rats. Pharmacol Biochem Behav 2002; 72: 483–490.
   PubMed Web of Science ®Google Scholar
• Gosnell BA, Levine AS, Morley JE. The stimulation of food intake by selective agonists of mu, kappa and delta opioid receptors. Life Sci 1986; 38: 1081–1088.
   PubMed Web of Science ®Google Scholar
• Morley JE, Levine AS, Kneip J, Grace M, Zeugner H, Shearman GT. The kappa opioid receptor and food intake. Eur J Pharmacol 1985; 112: 17–25.
   PubMed Web of Science ®Google Scholar
• Jackson A, Cooper SJ. Effects of kappa opiate agonists on palatable food consumption in non-deprived rats, with and without food preloads. Brain Res Bull 1985; 15: 391–396.
   PubMed Web of Science ®Google Scholar
• Nencini P, Graziani M. Opiatergic modulation of preparatory and consummatory components of feeding and drinking. Pharmacol Biochem Behav 1990; 37: 531–537.
   PubMed Web of Science ®Google Scholar
• Jarosz PA, Metzger BL. The effect of opioid antagonism on food intake behavior and body weight in a biobehavioral model of obese binge eating. Biol Res Nurs 2002; 3: 198–209.
   PubMedGoogle Scholar
• de Zwaan M, Mitchell JE. Opiate antagonists and eating behavior in humans: a review. J Clin Pharmacol 1992; 32: 1060–1072.
   PubMed Web of Science ®Google Scholar
• Barg J, Belcheva M, McHale R, Levy R, Vogel Z, Coscia CJ. Beta- endorphin is a potent inhibitor of thymidine incorporation into DNA via mu- and kappa-opioid receptor in fetal rat brain cell aggregates in culture. JNeurochem 1993; 60: 765–767.
   PubMed Web of Science ®Google Scholar
• Tseng LF, Henneberry B, Collins KA. The antinociception induced by beta-endorphin administered intrathecally is mediated by the activation of mu- and kappa-opioid receptors in the rat. Naunyn- Schmiedeberg’s Arch Pharmacol 1995; 351: 464–468.
   PubMed Web of Science ®Google Scholar